市場調查報告書
商品編碼
1479110
雷射誘導擊穿光譜市場:現況分析與預測(2023-2030)Laser-Induced Breakdown Spectroscopy Market: Current Analysis and Forecast (2023-2030) |
由於產品推出的增加,雷射誘導擊穿光譜市場預計將以 6.3% 左右的速度穩定成長。 例如,Hamamatsu Photonics於2023年9月發佈了最新的光譜儀 "OPAL-Luxe C16736-01" 。 在預測期內,有幾個因素正在推動市場成長,例如醫療保健領域 IT 基礎設施開發的進步。 除此之外,雷射誘導擊穿光譜技術的進步也正在以穩定的速度推動雷射誘導擊穿光譜市場。
依產品類型劃分,市場分為手持設備和桌上型設備。 到 2022 年,手持設備將因便攜性、易用性和技術進步而主導市場。 手持式雷射誘導擊穿光譜 (LIBS) 是一種用於元素分析的技術。 高能量雷射脈衝聚焦在樣品上,產生微等離子體並發射光。 分析發出的光以確定樣品的元素組成。 手持式儀器使 LIBS 變得便攜,適用於環境監測、法醫分析和工業品質控制等現場應用。 因此,在產品類型中,手持設備細分市場在2022年佔據了重要的市場佔有率。
根據最終用戶,市場分為學術/研究機構、製藥/生技公司等。 由於患有癌症和骨質疏鬆症等慢性疾病的患者數量不斷增加,預計製藥和生物技術公司部門在預測期內將佔據重要的市場佔有率。 例如,根據世界衛生組織 (WHO) 的數據,癌症是全球主要死亡原因,2020 年約有 1,000 萬人死於癌症,約佔死亡人數的六分之一。 製藥和生物技術公司越來越多地在其研究、開發和品質控製過程中利用 LIBS。 LIBS 具有快速分析、最少的樣品製備和無損性等優點,使其在這些行業中具有價值。 在製藥業,LIBS 可用於配方、原料和污染物的元素分析。 生物技術公司依靠 LIBS 進行各種應用,包括分析生物材料、監測發酵過程和表徵生物樣品。 因此,在預測期內,製藥和生物技術公司類別將在最終用戶中表現出更高的複合年增長率。
為了更瞭解雷射誘導擊穿光譜的市場介紹,市場包括北美(美國、加拿大、北美其他地區)、歐洲(德國、英國、法國、西班牙、義大利、歐洲其他地區)、亞洲太平洋地區。 在當前情況下,由於癌症和骨質疏鬆症等慢性疾病病例急劇增加、研發活動支出增加、研究舉措加強、對創新進展的投資以及企業合作的增加,北美地區預計將在 2022 年實現增長。它正在主導市場。 例如,根據2021 年5 月發表在《Science Direct》上的一項案例研究,事實證明,雷射誘導擊穿光譜對於植物生物學家確定美國環境中農藥和其他有害物質的毒理學作用非常有用,它已成為一種簡單的方法。 因此,依地區劃分,北美將在 2022 年佔據較大市場佔有率。
該市場的主要參與者包括 Thermo Fisher Scientific Inc.、SciAps, Inc.、Bruker Corporation、Princeton Instruments、Avantes 和 Applied Spectra。Laser-induced breakdown spectroscopy (LIBS) is an analytical technique used to determine the elemental composition of materials. It involves focusing a high-energy laser pulse onto a sample, which creates a micro-plasma or spark. This plasma emits light, which is then analyzed to identify the elements present in the sample based on their characteristic emission spectra. LIBS is used in various fields including laboratory assays, environmental monitoring, geological analysis, material science, archaeology, and industrial quality control due to its rapid and non-destructive nature. The increasing demand for quality control & process optimization and the LIBS's ability of non-destructive and rapid analysis lead to the market's growth. Several other factors, such as rising research & development activities, expanded applications in various industries like energy, metal & pharmaceutical, rising regulatory support, and a surge in government collaborations & partnerships are driving the laser-induced breakdown spectroscopy market globally.
The Laser-Induced Breakdown Spectroscopy Market is expected to grow at a steady rate of around 6.3% owing to the rising product launches. For instance, in September 2023, Hamamatsu Photonics launched its latest Spectrometer - the OPAL-Luxe C16736-01 which has applications like photoluminescence spectroscopy or laser-induced breakdown spectroscopy (LIBS). Several factors, including rising development of IT infrastructure in healthcare are driving the market's growth during the forecast period. Apart from this, technological advancements in laser-induced breakdown spectroscopy are also driving this market of laser-induced breakdown spectroscopy at a steady rate.
Based on the product type, the market is bifurcated into handheld and desktop. The handheld segment dominated the market in the year 2022 owing to technological advancements along with portability and user-friendly nature. Handheld laser-induced breakdown spectroscopy (LIBS) is a technique used for elemental analysis. It involves focusing a high-energy laser pulse onto a sample, creating a micro-plasma, which emits light. This emitted light is then analyzed to determine the elemental composition of the sample. Handheld devices make LIBS portable and suitable for in-field applications like environmental monitoring, forensic analysis, and industrial quality control. Thus, among the product types, the handheld segment held a significant market share in 2022.
Based on the end user, the market is categorized into academic & research institutes, pharmaceuticals & biotechnology companies, and others. The pharmaceuticals & biotechnology companies segment is expected to hold a significant share of the market in the forecast period owing to the rising chronic disease cases like cancer and osteoporosis. For instance, according to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Pharmaceutical and biotechnological companies are increasingly utilizing laser-induced breakdown spectroscopy (LIBS) in their research, development, and quality control processes. LIBS offers several advantages such as rapid analysis, minimal sample preparation, and non-destructive nature, making it valuable in these industries. In pharmaceuticals, LIBS can be employed for elemental analysis of drug formulations, raw materials, and contaminants detection. Biotechnological companies utilize LIBS for various applications including analysis of biomaterials, monitoring of fermentation processes, and characterization of biological samples. Thus, the pharmaceuticals & biotechnology companies category will witness a higher CAGR amongst end users during the forecast period.
For a better understanding of the market adoption of laser-induced breakdown spectroscopy, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of chronic diseases like cancer & osteoporosis, rising expenditure on research & development activities, rising research initiatives, investments in introducing innovative advancements, and rising company collaborations. For instance, according to a case study published in Science Direct in May 2021, laser-induced breakdown spectroscopy emerged as a straightforward bioimaging tool for plant biologists for assessment of photon-upconversion nanoparticles in Brassica oleracea L. plant, which is a plant species that belongs to ten recommended species by the United States Environmental Protection Agency for the determination of toxicological effects of pesticides and other toxic substances. Thus, amongst regions, North America held a significant share of the market in 2022.
Some of the major players operating in the market include Thermo Fisher Scientific Inc.; Hitachi High-Tech Analytical Science; SciAps, Inc.; Rigaku, Bruker Corporation; TSI; Princeton Instruments; Avantes; B&W Tek; Applied Spectra; SECOPTA analytics GmbH.